Workflow
Organ Logistics
icon
Search documents
4 Top Stocks Long-Term Investors Should Buy in March
The Motley Fool· 2026-03-08 07:55
Core Insights - March 2026 presents long-term investors with market pullbacks despite accelerating fundamentals, indicating potential investment opportunities [1] Company Summaries 1. Axon Enterprise - Axon has transformed into an AI-powered public safety platform, moving beyond its original product offerings of TASERs and body cameras [3] - Q4 2025 revenue reached $797 million, a 39% year-over-year increase, with full-year revenue at $2.8 billion, marking four consecutive years of over 30% growth [4] - Annual recurring revenue surpassed $1.3 billion, growing 35%, and future contracted bookings reached $14.4 billion, up 43% [4] - The company targets $6 billion in annual revenue by 2028 with 28% adjusted EBITDA margins, indicating significant growth potential [6] 2. Vertiv - Vertiv supplies power and cooling solutions for data centers, with demand surging due to the AI infrastructure build-out [8] - Full-year 2025 revenue was $10.2 billion, up 28% year-over-year, with adjusted operating margins expanding to 20.4% [9] - Organic orders increased by 81%, and the company ended 2025 with a backlog of $15 billion, equivalent to over a year of revenue [9] - The launch of OneCore integrated modular solutions and a Digital Twin platform positions Vertiv for continued growth in high-density AI data centers [10] 3. TransMedics Group - TransMedics operates the Organ Care System (OCS), revolutionizing organ transport by keeping donor organs warm during transit [12] - Full-year 2025 revenue reached $605.5 million, a 37% increase, with OCS Liver accounting for 36% of U.S. liver transplant procedures [13] - The company performed 5,139 U.S. OCS transplants in 2025, up from 3,735 in 2024, and is expanding into European markets [15] - TransMedics is positioned to dominate the organ logistics market with no viable competitors [16] 4. Fair Isaac - Fair Isaac is a leading credit score company, with its scores used in most mortgage, auto loan, and credit card decisions in the U.S. [17] - Fiscal year 2025 revenue was $1.99 billion, up 15.9%, with a net income of $651.9 million and a net profit margin of 32.8% [18] - The introduction of FICO Score 10T is expected to drive incremental licensing revenue, particularly in the mortgage market [20] - The company has announced a $1.5 billion stock buyback, indicating strong financial health and a favorable entry point for investors [21]